A detailed history of Graham Capital Management, L.P. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 2,231 shares of KRYS stock, worth $424,782. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,231
Previous 2,379 6.22%
Holding current value
$424,782
Previous $436,000 7.11%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$174.7 - $213.66 $25,855 - $31,621
-148 Reduced 6.22%
2,231 $405,000
Q2 2024

Aug 14, 2024

BUY
$153.12 - $183.64 $364,272 - $436,879
2,379 New
2,379 $436,000
Q3 2023

Nov 22, 2023

BUY
$108.51 - $130.22 $309,144 - $370,996
2,849 New
2,849 $330,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.89B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.